---
figid: PMC6520749__cancers-11-00465-g001
figtitle: The MAPK pathway in melanoma
organisms:
- NA
organisms_ner:
- Danio rerio
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC6520749
filename: cancers-11-00465-g001.jpg
figlink: /pmc/articles/PMC6520749/figure/cancers-11-00465-f001/
number: F1
caption: 'Schematic representation of the MAPK pathway in melanoma. Neuroblastoma
  RAS viral oncogene homolog (NRAS) and v-Raf murine sarcoma viral oncogene homolog
  B (BRAF) are the most commonly mutated oncogenes in melanoma and are strong activators
  of the MAPK pathway. Within this pathway negative feedback occurs towards mitogen-activated
  protein kinase kinase 1/2 (MEK1/2), BRAF and son of sevenless homolog (SOS). BRAF
  and MEK1/2 may by targeted by specific small molecule inhibitors. The activated
  MAPK pathway further activates transcription factors such as Ets-1, Elk-1, c-Fos,
  and CREB-1. Abbreviations: RTK, receptor tyrosine kinase; Shc, Src homology 2 domain
  containing adaptor protein; Grb-2, growth factor receptor bound protein 2; SOS,
  son of sevenless homolog. Ets-1, V-Ets avian erythroblastosis virus E26 oncogene;
  Elk-1, ETS-like gene 1; c-Fos, Fos proto-oncogene, AP-1 transcription factor subunit;
  CREB-1, CAMP responsive element binding protein 1.'
papertitle: Modelling of Protein Kinase Signaling Pathways in Melanoma and Other Cancers.
reftext: Manfred Kunz, et al. Cancers (Basel). 2019 Apr;11(4):465.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9457636
figid_alias: PMC6520749__F1
figtype: Figure
redirect_from: /figures/PMC6520749__F1
ndex: 64260c39-deea-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6520749__cancers-11-00465-g001.html
  '@type': Dataset
  description: 'Schematic representation of the MAPK pathway in melanoma. Neuroblastoma
    RAS viral oncogene homolog (NRAS) and v-Raf murine sarcoma viral oncogene homolog
    B (BRAF) are the most commonly mutated oncogenes in melanoma and are strong activators
    of the MAPK pathway. Within this pathway negative feedback occurs towards mitogen-activated
    protein kinase kinase 1/2 (MEK1/2), BRAF and son of sevenless homolog (SOS). BRAF
    and MEK1/2 may by targeted by specific small molecule inhibitors. The activated
    MAPK pathway further activates transcription factors such as Ets-1, Elk-1, c-Fos,
    and CREB-1. Abbreviations: RTK, receptor tyrosine kinase; Shc, Src homology 2
    domain containing adaptor protein; Grb-2, growth factor receptor bound protein
    2; SOS, son of sevenless homolog. Ets-1, V-Ets avian erythroblastosis virus E26
    oncogene; Elk-1, ETS-like gene 1; c-Fos, Fos proto-oncogene, AP-1 transcription
    factor subunit; CREB-1, CAMP responsive element binding protein 1.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - rab1ab
  - raf1a
  - braf
  - si:dkey-222f8.3
  - mapk3
  - ets1
  - elk1
  - fosab
  - creb1a
  - grb2b
  - map2k1
  - map2k2a
  - ras
  - Ras64B
  - Ras85D
  - Tie
  - InR
  - Sos
  - Raf
  - rl
  - kay
  - drk
  - Dsor1
  - KRAS
  - HRAS
  - NRAS
  - XYLT2
  - SOS1
  - SOS2
  - RAF1
  - BRAF
  - MAPK3
  - MAPK1
  - ETS1
  - ELK1
  - KCNH4
  - KCNH8
  - FOS
  - CREB1
  - GRB2
  - MAP2K1
  - MAP2K2
  - Vemurafenib
  - Dabrafenib
  - Encorafenib
  - Cobimetinib
  - Trametinib
  - Binimetinib
  - Cancer
  - Cardiomyopathy
  - Noonan syndrome
---
